David I. Fudman, M.D., is an Assistant Professor in the Department of Internal Medicine at UT Southwestern Medical Center, and a member of its Division of Digestive and Liver Diseases. He specializes in the treatment of inflammatory bowel diseases such as Crohn’s disease and ulcerative colitis.

Originally from Michigan, Dr. Fudman holds a bachelor's degree in biology and politics from Brandeis University in Waltham, Massachusetts. He earned his medical degree at UT Southwestern and completed a residency in internal medicine at New York-Presbyterian/Columbia University Medical Center. He then obtained advanced training in treating inflammatory bowel disease through a fellowship in gastroenterology and hepatology at Beth Israel-Deaconess Medical Center/Harvard Medical School in Boston.

Board certified in internal medicine, Dr. Fudman joined the UT Southwestern faculty in 2018. 

His research interests include Crohn's disease, quality improvement, inflammatory bowel disease, and ulcerative colitis.

Dr. Fudman is an active member of several professional organizations, including the American Gastroenterological Association, American College of Gastroenterology, and the Crohn's and Colitis Foundation.


Medical School
UT Southwestern Medical School (2011)
Columbia University Medical Center/New York Presbyterian Hospital (2014), Internal Medicine
Beth Isreal Deaconess Medical Center (2018), Gastroenterology

Research Interest

  • Inflammatory bowel disease
  • Quality improvement


Featured Publications LegendFeatured Publications

Systematic Review With Meta-analysis: Safety and Effectiveness of Combining Biologics and Small Molecules in Inflammatory Bowel Disease.
Alayo QA, Fenster M, Altayar O, Glassner KL, Llano E, Clark-Snustad K, Patel A, Kwapisz L, Yarur AJ, Cohen BL, Ciorba MA, Thomas D, Lee SD, Loftus EV, Fudman DI, Abraham BP, Colombel JF, Deepak P, Crohns Colitis 360 2022 Jan 4 1 otac002
Prevalence of Forceps Polypectomy of Non-Diminutive Polyps is Substantial but Modifiable.
Fudman DI, Singal AG, Cooper MG, Lee M, Murphy CC, Clin Gastroenterol Hepatol 2021 Nov
Visceral Adipose Tissue Volumetrics Inform Odds of Treatment Response and Risk of Subsequent Surgery in IBD Patients Starting Antitumor Necrosis Factor Therapy.
Gu P, Chhabra A, Chittajallu P, Chang C, Mendez D, Gilman A, Fudman DI, Xi Y, Feagins LA, Inflamm Bowel Dis 2021 Jul
Antibiotic prophylaxis and infectious complications in patients on peritoneal dialysis undergoing lower gastrointestinal endoscopy.
Clarke WT, Satyam VR, Fudman DI, Zullow S, Goyal KG, Byanova KL, Huang C, Feuerstein JD, Gastroenterol Rep (Oxf) 2020 Oct 8 5 407-409
Fragmentation, Care Models, and Improving Outcomes in Inflammatory Bowel Disease.
Fudman DI, Hou JK, JAMA Netw Open 2020 09 3 9 e2016122
High Rate of Incomplete Consent for Colonoscopy: Identifying an Area for Improvement in Gastrointestinal Endoscopy.
Fudman DI, Roemi L, Leffler DA, Feuerstein JD, Am J Med Qual 2019 Aug 1062860619868296
Complication rates of trainee- versus attending-performed upper gastrointestinal endoscopy.
Fudman DI, Falchuk KR, Feuerstein JD, Ann Gastroenterol 2019 May-Jun 32 3 273-277
Inpatient Management of Acute Severe Ulcerative Colitis.
Fudman DI, Sattler L, Feuerstein JD, J Hosp Med 2019 May 14 E1-E8
Effect of Consent and Educational Adjuncts to Consent on Patient Perceptions About Colonoscopy.
Fudman DI, Papamichael K, Roemi L, Rao V, Falchuk KR, Leffler DA, Feuerstein JD J. Clin. Gastroenterol. 2018 Jul


Featured Books Legend Featured Books

Anti-TNF Therapy for Treatment of Extraintestinal Manifestations of Inflammatory Bowel Disease. In Treatment of Inflammatory Bowel Disease with Biologics

Fudman DI, Flier SN (2017). Springer

Honors & Awards

  • Fellowship Award for Quality Improvement
    Beth Israel Deaconess Medical Center (2017)
  • Presidential Merit Scholarship
    Brandeis University (2003)

Professional Associations/Affiliations

  • American College of Gastroenterology
  • American Gastroenterological Association
  • Crohn’s & Colitis Foundation of America